Supplement GMP proposal "one-size-fits-all" approach is "naive," commenters maintain.
This article was originally published in The Tan Sheet
Executive Summary
SUPPLEMENT GMP PROPOSAL "ONE-SIZE-FITS-ALL" APPROACH "NAIVE" both technologically and scientifically, a group of joint commenters proclaim in May 7 comments to FDA on the Feb. 7 advance notice of proposed rulemaking suggesting Good Manufacturing Practices regulations for the dietary supplement industry ("The Tan Sheet" Feb. 10, p. 2). The one-size-fits-all approach of the ANPR -- i.e., the same regulatory oversight for companies that just fill capsules and those who grow botanicals and process them -- "is based on a faulty assumption that dietary supplements are, to a degree, fungible when they are extraordinarily diverse and are produced using vastly different techniques and methods of production," the commenters maintain.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning